Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light‐Activatable Implant
The Laryngoscope · 2026
DOI: 10.1002/lary.70149 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Denzel Ryan D Cruz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Dexamethasone, Vocal Cords, Cicatrix, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIDCD NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Objective
Intralesional steroid injections for vocal fold (VF) scarring are rapidly cleared, limiting their effectiveness. This study evaluates the efficacy of a light‐activatable dexamethasone implant compared to a single steroid injection for VF scar healing.
Methods
Ten rabbits underwent endoscopic VF injury and were treated with either a dexamethasone injection or a light‐activatable implant; injured‐only and no‐injury VFs served as controls. On days 0 and 21, VF implants were irradiated with a near‐infrared pulsed laser for 1 min. Larynges were harvested after 42 days. High‐speed video (> 10 kHz) of excised larynges captured VF vibrations for kymographic analysis. Normal force, structural stiffness, and displacement were measured. Data were analyzed with appropriate statistical tests.
Results
Compared to injury‐only VFs, implant‐treated VFs demonstrated significantly reduced normal force and stiffness (5.28 ± 0.77 mN vs. 2.34 ± 0.66 mN, p < 0.0001; 17.74 ± 2.45 mN/mm vs. 6.80 ± 1.32 mN/mm, p < 0.0001), and increased displacement at 1.96 mN (0.14 ± 0.02 mm vs. 0.29 ± 0.05 mm, p < 0.0001) along the injury zone. Implant‐treated VFs exhibited larger amplitude ratios and improved tissue architecture than untreated scars. No differences in quantitative measures were observed between implant‐treated and injection‐treated groups.
Conclusion
A light‐activatable dexamethasone implant improved VF biomechanics, vibratory behavior, and histological outcomes in a rabbit injury model comparable to a single steroid injection. This novel approach shows promise for delivering controlled, repeatable therapy to VF scars.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Scientist Training Program, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Biomedical Engineering, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Otolaryngology-Head and Neck Surgery, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Chemical and Environmental Engineering, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, Ohio, USA.
ORCID-Profile: Denzel Ryan D Cruz, Nour Awad, Avery Zheng, Alexander Karabachev, Charles Farbos de Luzan, Yoonjee C Park, Gregory R Dion
Förderung
- NCATS NIH HHS
- NIDCD NIH HHS
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Cruz, D. R. D., Awad, N., Zheng, A., Karabachev, A., Farbos de Luzan, C., Park, Y. C., & Dion, G. R. (2026). Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light‐Activatable Implant. The Laryngoscope. https://doi.org/10.1002/lary.70149
Vancouver
Cruz DRD, Awad N, Zheng A, Karabachev A, Farbos de Luzan C, Park YC, et al. Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light‐Activatable Implant. The Laryngoscope. 2026. doi:10.1002/lary.70149
BibTeX
@article{Cruz2026,
author = {Cruz, Denzel Ryan D and Awad, Nour and Zheng, Avery and Karabachev, Alexander and Farbos de Luzan, Charles and Park, Yoonjee C and Dion, Gregory R},
title = {Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light‐Activatable Implant},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70149}
}
EUVIMED